An estimated 58 Nigerian women die from breast cancer every day, with experts warning that late diagnosis, unaffordable treatment and inadequate cancer-care infrastructure are driving the country’s high mortality rate.
The latest Global Cancer Observatory (GLOBOCAN 2024) estimates show that Nigeria recorded 44,196 new breast cancer cases and 21,309 deaths in 2024, making breast cancer the country’s most common cancer.
Ifeoma J. Okoye, an emeritus professor and global health leader, said breast cancer accounts for 29 per cent of all new cancer cases in Nigeria and nearly half of cancers diagnosed among Nigerian women.
She said the figures translate to roughly one Nigerian woman being diagnosed with breast cancer every 12 minutes and another dying from the disease every 25 minutes.
The growing burden is being compounded by delays in diagnosis and treatment, with many women reaching health facilities only after the disease has advanced.
A 2025 Cancer Control Capacity and Needs Assessment cited by Okoye found that more than 70 per cent of cancer patients in Nigeria present with advanced disease.
A separate 2025 study involving 264 cancer patients in Kano and Ibadan found that the median period between noticing symptoms and receiving a diagnosis was 12 months. Patients visited a median of three health facilities before receiving a diagnosis.
For some women, the delay begins outside the formal healthcare system.
A study conducted in Ilesa, Osun State, found that women who initially sought treatment from herbal homes took an average of 89 weeks — nearly two years — to reach cancer treatment, often arriving with more advanced tumours.
Experts said myths, stigma and misinformation also contribute to delayed treatment. Some women interpret breast lumps as spiritual attacks, fear that biopsy could spread cancer or regard a cancer diagnosis as an automatic death sentence.
The financial burden is another major obstacle.
Okoye estimated that treating stage II breast cancer in Nigeria could cost about ₦25 million, with many families paying out of pocket. She said patients sometimes interrupt or abandon treatment when they exhaust their resources.
The country also faces a severe shortage of cancer treatment infrastructure and specialists. According to the 2025 national assessment, Nigeria had only 13 functional radiotherapy machines against an estimated need of more than 120, while oncologists stood at about 0.03 per 100,000 people.
Access to mammography, breast ultrasound, biopsy services and receptor testing is also concentrated largely in major cities, leaving women in rural and underserved communities facing long journeys before diagnosis and treatment.
The human cost is reflected in the experiences of families who have lost loved ones.
Chinedu Mike lost his 42-year-old wife after a three-year battle with breast cancer, leaving him with four children and mounting debts. His wife had to travel from their local government area to the state capital and later Abuja for treatment because of the lack of adequate cancer services nearby.
Fatima Nuhu lost her 45-year-old sister in March after a five-year struggle that included mastectomy, chemotherapy and radiotherapy. Treatment was repeatedly interrupted because the family could no longer afford it or access radiotherapy promptly.
Another family, led by Temitayo, lost their 60-year-old mother despite her cancer being diagnosed at stage two. At one point, a chemotherapy medicine prescribed for her reportedly cost ₦1.5 million, far above the ₦200,000 the family had expected to pay.
Some survivors, however, have overcome the odds.
Gloria Orji, diagnosed in 2010 and treated again after a recurrence in 2018, underwent chemotherapy, radiotherapy and years of hormonal treatment.
Another survivor, Gloria Okwu, underwent a mastectomy, more than 25 chemotherapy sessions, about 35 radiotherapy sessions and targeted therapy after being diagnosed in 2016.
She said Nigeria’s cancer-care system remains constrained by high treatment costs, inadequate infrastructure, limited equipment, shortage of qualified oncologists and insufficient psychological support.
The rising incidence is also reflected in recent research. A study published in The Lancet Oncology found that breast cancer incidence among Nigerian women increased by 145.5 per cent between 2010 and 2022, rising from 54.3 cases per 100,000 women to 133.3 cases per 100,000.
Okoye said GLOBOCAN estimates indicate that about 48 out of every 100 Nigerian women diagnosed with breast cancer are expected to die from the disease.
She said evidence from the University College Hospital, Ibadan, showed that only 37.6 per cent of women who received optimal treatment were alive five years after diagnosis. More than half presented with stage III disease, while 28 per cent had cancer that had already spread to other parts of the body.
Experts are therefore calling for stronger government intervention, including expanded health insurance coverage, increased funding for cancer treatment, improved radiotherapy services and wider access to early diagnosis.
Okoye advocated well-equipped breast clinics across the six geopolitical zones, where women could access imaging, biopsies and receptor testing in one location.
She also called for stronger primary healthcare services, training of community health workers, improved cancer registration and increased investment in oncology specialists and essential medicines.
Usman Samuel Nganjiwa, a breast cancer specialist at the University of Maiduguri Teaching Hospital, similarly urged authorities to decentralise cancer care and establish at least one specialised cancer centre in each geopolitical zone.
He said awareness campaigns should extend beyond hospitals and October breast cancer campaigns to schools, markets, religious centres and communities.
The Federal Government has also announced plans to expand cancer screening. The Federal Ministry of Health and Social Welfare said it had commenced a pilot programme of preventive oncology clinics in six centres, with plans to integrate basic cancer screening into primary healthcare centres before May 2027.
However, a review of Nigeria’s cancer screening programme found that implementation of a nationwide breast cancer screening programme remained at the planning and early pilot stages.
Experts stressed that awareness alone will not be enough without affordable and accessible treatment.
As Okoye put it, “No amount of awareness can save a woman who cannot afford her treatment.”
For Nigerian women, the challenge therefore goes beyond detecting breast cancer. It is also about ensuring that a diagnosis does not become a financial death sentence.
Source: ICIR
